Attention postmenopausal women age 50+ with Osteoporosis.

Osteoporosis Research Studies are enrolling now.

Those who qualify may receive*:

  • Payment up to $500, which varies by study
  • Study-related care at no cost from local doctors
  • Study medication at no cost

Plus, no cost to you.
No health insurance or referral needed

Ready to get started? Click Here.

Osteoporosis is a disease that cause bones to become weak and brittle over time. It is known as a silent disease, because there are usually no symptoms until you fracture or break a bone.

  • Osteoporosis is typically caused by hormonal changes or a deficiency of calcium or vitamin D. Women who have gone through menopause are at higher risk of osteoporosis due to the loss of estrogen.
  • Right now, local doctors are evaluating a new form of an already FDA-approved medication to test its ability to rebuild bone and reduce risk of fractures. There is no chance of receiving an inactive form of medication in the studies – participants receive either the approved form or the study medication, a patch.

If you are seeking options for managing your bone health, considering joining a clinical trial. There is no cost to participate, and you do not need health insurance.

* In a research study, the participants may receive investigational study product or may receive an inactive substance, or placebo, depending on the study design. Participants receive study-related care from a doctor/research team for the duration of the study. For studies that offer compensation, reasonable payments will be made for participation. The length of the study may vary.

Ready to get started?

Click here.

How does it work?

1

Tell us a little bit about yourself

2

Answer some questions about your health

3

We will connect you to available studies in your area

Just takes a few minutes

AcurianHealth

AcurianHealth helps connect people with research studies that offer treatment under development. Since 1998, AcurianHealth has referred 1 million study candidates to 800 studies in 70 countries.